Trials / Terminated
TerminatedNCT03404089
Bedside Therapeutic Monitoring of β-Lactam Levels in Newborns, Children and Adolescents Admitted to Intensive Care.
Bedside Therapeutic Monitoring of β-Lactam Levels in Newborns, Children and Adolescents Admitted to Intensive Care: Study of a Pharmacokinetics Monitoring Method.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluate the capacity of the MON4STRAT device for drug monitoring of β- lactam antibiotic concentrations in newborns, children, and adolescents admitted in intensive care units with a health care-associated infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | pharmacokinetic device | MON4STRAT system: bed-side pharmacokinetic device for drug concentration measurement |
| DEVICE | pharmacokinetic device | High performance liquid chromatography, (HPLC), the reference methods HLPC tandem mass spectrometry or Ultraviolet are using |
Timeline
- Start date
- 2018-04-18
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
- First posted
- 2018-01-19
- Last updated
- 2023-01-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03404089. Inclusion in this directory is not an endorsement.